QUALITATIVE AND QUANTITATIVE COMPOSITION
Human Epidermal growth produced by recombinant DNA technology. Each gram of gel contains 150 μg recombinant human epidermal growth factor
Indicated for topical healing of neuropathic diabetic foot ulcers
Available in printed laminated tube with white cover in a carton box.
Provided in gel base REGEN-D 150 is to be spread evenly (topical application) on affected part using a sterile cotton swab twice a day till the ulcer heals. REGEN-D 150 therapy should be continued up to a period of 8 to 12 weeks. The continuation of the therapy is at the discretion of the physician.
MARKETING AUTHORIZATION HOLDER